Literature DB >> 12923349

Gliofibroma: a case report and review of the literature.

Yoonjung Kim1, Yeon Lim Suh, Changohk Sung, Seung Chyul Hong.   

Abstract

Gliofibroma is a rare astrocytic tumor, composed of a glial component ranging from benign to high grade of malignancy and a consistently benign mesenchymal component. Its exact biological behavior is not fully known. In addition, histogenesis and prognostic factors are also still debatable. We herein present a rare case of gliofibroma in a 25-yr-old male with seizure. A computed tomographic scan of the brain showed a 1.5 cm-sized, enhancing mass with calcification. Histologically, the tumor consisted of glial fibrillary acidic protein (GFAP)-positive glial cells admixed with a mesenchymal component and extensive collagen lay down. The glial cells displayed variable cellularity, but without mitosis or necrosis. Since the MIB-1 labeling index was up to 35.8% in the cellular areas of the glial component, it could be considered to be a predictor of worse prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923349      PMCID: PMC3055071          DOI: 10.3346/jkms.2003.18.4.625

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  3 in total

1.  WHO Grade IV Gliofibroma: A Grading Label Denoting Malignancy for an Otherwise Commonly Misinterpreted Neoplasm.

Authors:  Paola A Escalante Abril; Miguel Fdo Salazar; Nubia L López García; Mónica N Madrazo Moya; Yadir U Zamora Guerra; Yadira Gandhi Mata Mendoza; Erick Gómez Apo; Laura G Chávez Macías
Journal:  J Pathol Transl Med       Date:  2015-07-15

2.  Intracranial gliofibroma: a case report and review of the literature.

Authors:  Patricia Gargano; Graciela Zuccaro; Fabiana Lubieniecki
Journal:  Case Rep Pathol       Date:  2014-07-13

3.  Adult Intracranial Gliofibroma : A Case Report and Review of the Literature.

Authors:  Ho Kang; Jin Wook Kim; Young-Bem Se; Sung-Hye Park
Journal:  J Korean Neurosurg Soc       Date:  2016-05-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.